Composition CJC-1295 (Without DAC): 5 mg Ipamorelin: 5 mg Appearance: Lyophilized powder in a sealed research vial Research Focus (non-clinical) Comparative and combined pathway evaluation of GHRH analog + GHS agonist in in-vitro or ex-vivo models Assessment of assay development, including chromatographic separation of co-formulated peptides Stability characterization of a two-analyte lyophilized blend under laboratory storage conditions Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Expected timeline to market If the TRIUMPH trials produce results consistent with Phase 2, regulatory submission could occur as early as late next year, with approval and market availability following twelve to eighteen months later
If youve got experience in Beauty, E-commerce, or FMCG, love brainstorming creative campaign ideas, and enjoy working with influencers
IV delivery bypasses the digestive breakdown that limits oral glutathione absorption, resulting in higher bioavailability